Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group Study to Evaluate the Safety and Efficacy of CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Status: Enrolling
Updated:  11/30/2016
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group Study to Evaluate the Safety and Efficacy of CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Status: Enrolling
Updated: 11/30/2016
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group Study to Evaluate the Safety and Efficacy of CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Status: Enrolling
Updated:  11/30/2016
Hopital Saint-Louis
mi
from
Paris,
A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Parallel-Group Study to Evaluate the Safety and Efficacy of CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
Status: Enrolling
Updated: 11/30/2016
Hopital Saint-Louis
mi
from
Paris,
Click here to add this to my saved trials
Advanced Gastrointestinal Endoscopic Imaging
Advanced Gastrointestinal Endoscopic Imaging
Status: Enrolling
Updated:  12/5/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Advanced Gastrointestinal Endoscopic Imaging
Advanced Gastrointestinal Endoscopic Imaging
Status: Enrolling
Updated: 12/5/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
Emory University
mi
from
Atlanta, GA
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
University of South Carolina
mi
from
West Columbia, SC
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
University of South Carolina
mi
from
West Columbia, SC
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
USC/Norris Comprehensice Cancer Center
mi
from
Los Angeles-, CA
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
USC/Norris Comprehensice Cancer Center
mi
from
Los Angeles-, CA
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
University of Colorado Health Sciences Center
mi
from
Denver, CO
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
University of Colorado Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
University of Iowa Hospitals & Clinic
mi
from
Iowa City, IA
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
University of Iowa Hospitals & Clinic
mi
from
Iowa City, IA
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated:  12/7/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
Status: Enrolling
Updated: 12/7/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Coronado, CA
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Coronado, CA
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
La Jolla, CA
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
San Diego, CA
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
San Diego, CA
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Gainesville, FL
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Miami, FL
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Tampa, FL
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Manhasset, NY
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
New York, NY
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Charlotte, NC
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Dallas, TX
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Houston, TX
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
San Antonio, TX
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated:  12/7/2016
Clinical Research Facility
mi
from
Seattle, WA
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection, With Severe Renal Impairment or End-Stage Renal Disease (RUBY-I)
Status: Enrolling
Updated: 12/7/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Goal-directed Fluid Resuscitation in Acute Pancreatitis
A Randomized-controlled Trial of a Targeted Approach to Fluid Resuscitation in Acute Pancreatitis
Status: Enrolling
Updated:  12/8/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Goal-directed Fluid Resuscitation in Acute Pancreatitis
A Randomized-controlled Trial of a Targeted Approach to Fluid Resuscitation in Acute Pancreatitis
Status: Enrolling
Updated: 12/8/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Compassionate Use of Stanate (TM) [Stannsoporfin]
Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions
Status: Enrolling
Updated:  12/12/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Compassionate Use of Stanate (TM) [Stannsoporfin]
Compassionate Use of Stannsoporfin as an Adjuvant to Phototherapy to Reduce the Need for Exchange Transfusions
Status: Enrolling
Updated: 12/12/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control
Status: Enrolling
Updated:  12/14/2016
Temple University School of Podiatric Medicine Gait Study Center
mi
from
Philadelphia, PA
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control
Status: Enrolling
Updated: 12/14/2016
Temple University School of Podiatric Medicine Gait Study Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
EoE(Eosinophilic Esophagitis)
Quantitative MRI Evaluation of Esophageal Remodeling/Response to Treatment in Children and Adolescents With Eosinophilic Esophagitis Presenting With Dysphagia
Status: Enrolling
Updated:  12/15/2016
University of Michigan C. S. Mott Children's Hospital
mi
from
Ann Arbor, MI
EoE(Eosinophilic Esophagitis)
Quantitative MRI Evaluation of Esophageal Remodeling/Response to Treatment in Children and Adolescents With Eosinophilic Esophagitis Presenting With Dysphagia
Status: Enrolling
Updated: 12/15/2016
University of Michigan C. S. Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Study of KCC Peptide Application in the Colon
Phase 1B Study of KCC Peptide Application in the Colon
Status: Enrolling
Updated:  12/15/2016
University of Michigan
mi
from
Ann Arbor, MI
Study of KCC Peptide Application in the Colon
Phase 1B Study of KCC Peptide Application in the Colon
Status: Enrolling
Updated: 12/15/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
Status: Enrolling
Updated:  12/15/2016
University of Michigan Hospital
mi
from
Ann Arbor, MI
Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
Is Eovist Suitable for Arterial-Phase MR Imaging of Liver
Status: Enrolling
Updated: 12/15/2016
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Status: Enrolling
Updated:  12/19/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Status: Enrolling
Updated: 12/19/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Status: Enrolling
Updated:  12/19/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Status: Enrolling
Updated: 12/19/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Status: Enrolling
Updated:  12/19/2016
Academic Medical Center
mi
from
Amsterdam,
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
Status: Enrolling
Updated: 12/19/2016
Academic Medical Center
mi
from
Amsterdam,
Click here to add this to my saved trials
Medications Development for Drug Abuse Disorders
Medications Development for Drug Abuse Disorders
Status: Enrolling
Updated:  12/20/2016
Johns Hopkins University (BPRU) Bayview Campus
mi
from
Baltimore, MD
Medications Development for Drug Abuse Disorders
Medications Development for Drug Abuse Disorders
Status: Enrolling
Updated: 12/20/2016
Johns Hopkins University (BPRU) Bayview Campus
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
Status: Enrolling
Updated:  12/22/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
Status: Enrolling
Updated: 12/22/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Phase 1 meCS6 + LT(R192G) Vaccine Study
Safety and Immunogenicity of Oral Microencapsulated CS6 Vaccine and LT(R192G) Adjuvant in Volunteers
Status: Enrolling
Updated:  12/27/2016
Walter Reed Army Institute for Research
mi
from
Silver Spring, MD
Phase 1 meCS6 + LT(R192G) Vaccine Study
Safety and Immunogenicity of Oral Microencapsulated CS6 Vaccine and LT(R192G) Adjuvant in Volunteers
Status: Enrolling
Updated: 12/27/2016
Walter Reed Army Institute for Research
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound.
Status: Enrolling
Updated:  12/28/2016
LIJ Medical Center- NSLIJ Health System
mi
from
New Hyde Park, NY
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound.
Status: Enrolling
Updated: 12/28/2016
LIJ Medical Center- NSLIJ Health System
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
National City, CA
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Denver, CO
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Golden, CO
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Golden, CO
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Maitland, FL
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Winter Park, FL
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Zephyrhills, FL
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Suwanee, GA
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Suwanee, GA
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  1/4/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials